Acquired Hemophilia A (AHA) related to pregnancy is a rare but life-threatening autoimmune disorder where the body develops antibodies against its own clotting Factor VIII. Unlike hereditary hemophilia, which is genetic, this form typically appears in women with no prior history of bleeding. It most commonly occurs in the , often 1 to 4 months after delivery. Key Features & Diagnosis
Used to stop active bleeding by circumventing the inhibited Factor VIII. Download HГ©mophilie acquise grossesse pdf
Low levels of Factor VIII and the presence of a specific anti-Factor VIII inhibitor. Management and Treatment Acquired Hemophilia A (AHA) related to pregnancy is
Sudden, severe bruising (ecchymosis), mucosal bleeding, or prolonged bleeding after delivery. Key Features & Diagnosis Used to stop active
Recombinant activated Factor VII (rFVIIa) or activated prothrombin complex concentrates (FEIBA). Eradicating the Inhibitor
Treatment requires a multidisciplinary approach involving hematologists, obstetricians, and neonatologists. Controlling Bleeding
An isolated prolongation of the activated partial thromboplastin time (aPTT) that does not correct when mixed with normal plasma.